Recovery
BPC-157 (10mg)
R550
Recovery
CJC-1295 (without DAC) + Ipamorelin
CJC-1295 (No DAC) 5mg + Ipamorelin (IPA) 5mg is a complementary peptide combination designed to support natural growth hormone pulsatility.
R800
1
- Includes enough bacteriostatic water to reconstitute this vial, at no extra cost.
- Courier delivery across South Africa, 2 to 5 business days.
- Dispatched within 1 to 2 business days with tracking.
- Supplied for research and educational purposes only.
- No change-of-mind returns. Anything damaged, faulty or incorrect is replaced or refunded.
Recommended by the Stack Finder in
What the research says
GHRH analogue, short-acting
CJC-1295 (no DAC)
A short-acting GHRH analogue that produces a natural growth hormone pulse, usually paired with ipamorelin.
- How it works
- Binds GHRH receptors in the pituitary to amplify the body's own growth hormone pulse, particularly the large pulse in early sleep.
- Research status
- The published human studies used the DAC form; this modified GHRH(1-29) molecule itself has no trials, and the sleep evidence comes from related GHRH and secretagogue studies.
- Cautions
- Raises IGF-1; avoid with active cancer or a recent cancer history.
- Can cause water retention, tingling hands and transient blood sugar changes.
Key studies
Pulsatile growth hormone secretion is preserved during CJC-1295 (DAC form) stimulation in healthy adults.
Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab. 2006;91:4792-4797. doi:10.1210/jc.2006-1702
GHRH itself promoted slow-wave sleep in healthy men, the mechanism a GHRH analogue is expected to share.
Kerkhofs M et al. Sleep-promoting effects of growth hormone-releasing hormone in normal men. Am J Physiol. 1993;264:E594-E598. doi:10.1152/ajpendo.1993.264.4.E594
Oral MK-677, a different growth hormone secretagogue, increased deep (stage IV) sleep by about 50% in young men; no sleep study of CJC-1295 or ipamorelin exists.
Copinschi G et al. Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in man. Neuroendocrinology. 1997;66:278-286. doi:10.1159/000127249
Selective growth hormone secretagogue (ghrelin mimetic)
Ipamorelin
The most selective growth-hormone-releasing peptide, with human safety data from a phase 2 surgical trial.
- How it works
- Activates the ghrelin receptor in the pituitary to release growth hormone without the cortisol or prolactin rise seen with older GHRPs.
- Research status
- Human pharmacokinetic studies and a randomised phase 2 trial (for post-operative ileus, which it did not treat effectively) establish safety; no body-composition outcome trials.
- Cautions
- Raises growth hormone and IGF-1; avoid with active cancer or a recent cancer history.
- Mild hunger and headaches are the most reported effects.
Key studies
Released growth hormone selectively, with no increase in cortisol or prolactin at effective doses.
Raun K et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139:552-561. doi:10.1530/eje.0.1390552
Intravenous ipamorelin was well tolerated in a randomised trial of 117 surgical patients.
Beck DE et al. Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients. Int J Colorectal Dis. 2014;29:1527-1534. doi:10.1007/s00384-014-2030-8
About this product
CJC-1295 (No DAC) 5mg + Ipamorelin (IPA) 5mg is a complementary peptide combination designed to support natural growth hormone pulsatility.
This stack is particularly suited for individuals seeking improved recovery, sleep quality, tissue repair, and body composition support without excessive stimulation or hormonal disruption.
WHAT IS CJC-1295 (NO DAC) + IPAMORELIN?
CJC-1295 (No DAC) is a growth hormone–releasing hormone (GHRH) analogue that stimulates the pituitary to release growth hormone in a physiologic, pulsatile manner.
Ipamorelin is a selective growth hormone secretagogue (GHS) that enhances growth hormone release while maintaining a low side-effect profile, with minimal impact on cortisol or prolactin levels.
Together, they work synergistically to support natural growth hormone signalling without continuous overstimulation.
RECOVERY, SLEEP & BODY COMPOSITION SUPPORT
Growth hormone plays a central role in tissue repair, recovery, sleep architecture, and metabolic regulation. Suboptimal GH signalling is often associated with poor recovery, disrupted sleep, and reduced body composition efficiency.
By supporting healthy GH pulses — particularly during sleep — this combination may assist in enhancing overnight recovery, promoting deeper sleep quality, and supporting lean tissue maintenance.
KEY BENEFITS
• Supports natural growth hormone release
• Enhances recovery and tissue repair
• Promotes deeper, restorative sleep
• Supports lean mass and body composition
• Low-side-effect, non-stimulant approach
WHO THIS COMBINATION IS IDEAL FOR
CJC-1295 (No DAC) + Ipamorelin is well suited for individuals who:
• Want improved recovery and sleep quality
• Support training or active lifestyles
• Prefer physiologic, pulse-based GH support
• Seek body composition optimisation without stimulants
• Are focused on long-term wellness and resilience
PRODUCT DETAILS
• Peptides: CJC-1295 (No DAC) + Ipamorelin (IPA)
• Amount: 5mg + 5mg per vial
• Format: Lyophilised (freeze-dried) powder
• Category: Recovery | Sleep Support | Body Composition
• Storage: Refrigerate after reconstitution
WHAT YOU’LL ALSO NEED
This peptide requires reconstitution prior to use. Bacteriostatic water is included with your order for convenience.
• Reconstitution Syringe
• Insulin Syringes
• Alcohol Swabs
These essentials can be added below for convenience.
FAQ
Q: Why are CJC-1295 and Ipamorelin combined?
A: They are often explored together due to complementary roles in growth hormone signalling pathways.
Q: How does this differ from using Ipamorelin alone?
A: The combination is commonly discussed as providing a more complete and sustained signalling response.
Q: What makes this a more comprehensive GH approach?
A: It is typically positioned as supporting both signalling initiation and amplification rather than a single mechanism.
IMPORTANT NOTE
This product is intended for research and educational purposes only.
Always consult a qualified healthcare professional before beginning any new peptide protocol.
